A federal judge in Washington D.C. has blocked the FDA's attempt to regulate premium cigars.
U.S. District Court Judge Amit P. Mehta in Washington D.C. ruled that the FDA ignored scientific evidence when it included premium cigars in its Proposed Rule Deeming Tobacco Products to Be Subject to the Family Smoking Prevention and Tobacco Control Act .
During court proceedings, the Cigar Association of America presented evidence that an FDA-funded study showed cigar smokers do not have higher “all-cause” mortality rates than non-smokers. “The agency then ignored relevant data in the record that commentors had highlighted and inexplicably made a ‘no data’ finding,” Mehta ruled. “The significance of the agency’s error supports vacatur.”
As a result of the ruling, the FDA would need to restart the rulemaking process if it chooses to, the Cigar Association said in a news release. “This is a big victory for cigar enthusiasts across America," CAA President David Ozgo said in a statement."The evidence clearly showed the public would receive little benefit resulting from FDA regulation of premium cigars. Moreover, regulation would add burdensome costs to all premium cigar manufacturers which cannot be justified.”
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Cigar Thoughts Podcast, Episode 94: Antonio Cromartie“Cigar Thoughts Podcast: Antonio Cromartie” The All Pro DB Cro31 lights up a stogie and chops up the Seahawks secondary with JacsonBevens + MikeBarwin in the final installment of the CigarThoughts 2023 Positional Breakdown Series
Read more »
FDA Approves First Postpartum Depression Pill in the USIt’s estimated that each year in the U.S., more than 400,000 babies are born to mothers who are depressed. Without any treatment, postpartum depression can last for months or even years, according to the National Institute of Mental Health.
Read more »
FDA approves first pill specifically designed to treat postpartum depressionFDA APPROVED: Doctors say postpartum depression is a condition that can start during pregnancy with symptoms such as feelings of sadness, guilt, loss of energy and difficulty sleeping.
Read more »
Sage Therapeutics stock plunges 48% after FDA decision on postpartum depression drugThe FDA approved the pill Zuranolone, developed by Sage and Biogen, for postpartum depression but declined to approve it for major depressive disorder.
Read more »
FDA approves first postpartum depression pillThe medication is a first-of-its-kind treatment in the United States for a condition that affects thousands of new mothers every year.
Read more »